Performance of Handheld NaI(Tl) Spectrometers as Dosimeters by Laboratory and Field Dose Rate Measurements

Performance of Handheld NaI(Tl) Spectrometers as Dosimeters by Laboratory and Field Dose Rate Measurements

Within the framework of the IAEA Coordinated Analysis Challenge (CRP) J02012 on ‘Advancing Radiation Detection Tools for Detecting Nuclear and Different Radioactive Materials Out of Regulatory Management’, the properties of two industrial devices (1) InSpector 1000 analyzer (Canberra), with a 2″ × 2″ NaI(Tl) scintillator and (2) RIIDEYE M-G3 analyzer (Thermo Scientific), with a 3″ × 3″ NaI(Tl) scintillator, have been evaluated as dosimeters by laboratory and area measurements.
Within the Ionizing Radiation Calibration Laboratory (IRCL) of the Greek Atomic Power Fee, the NaI(Tl) spectrometers have been examined in an effort to measure Ambient gamma Dose Equal Price (ADER). The NaI(Tl) scintillators have been irradiated in a homogeneous area with 662 keV photons with completely different ADER values from 0.17 to 100 μSv h-1 at 0° incidence (irradiation area perpendicular to the detector’s entrance window) and at 90° incidence.
For every irradiation, the measured ADER by the spectrometers and the ‘true’ ADER values (offered by the IRCL) have been in contrast. As well as, the angular dependence (0-359°) of the ADER response of the spectrometers was studied with a 152Eu supply positioned at 1, 2 and three m from the spectrometers. The ADER dependence as perform of the space from the 152Eu supply (at 0° incidence) measured by the 2 detectors was in contrast with the theoretical one.
Within the area research, ADER was measured by the spectrometers at seven areas belonging to the Greek Early Warning System Community (which is predicated on Reuter-Stokes ionization chambers). These areas have completely different ADER values starting from 20 to 120 nSv h-1. In these areas, gamma ADER have been additionally deduced (1) by in situ gamma spectrometry measurements with moveable Germanium HPGe detectors and (2) by the Reuter-Stokes ionization chambers (by subtraction of the cosmic radiation).
Gamma dose measurements have been additionally carried out with the InSpector 1000 and RIIDEYE M-G3 detectors in 25 areas (seashores) of Northern Greece and in contrast with the ADER values deduced by sand pattern evaluation with gamma spectroscopy. Seashores with sand are good candidates for such kind of measurements since they’re generally flat and in precept the pure radionuclides are homogenously distributed.

Design and optimization of a complicated time-of-flight neutron spectrometer for deuterium plasmas of the massive helical system

A time-of-flight neutron spectrometer based mostly on the Time-Of-Flight Enhanced Diagnostic (TOFED) idea has been designed and is beneath improvement for the Massive Helical Gadget (LHD). Will probably be the primary superior neutron spectrometer to measure the two.45 MeV D-D neutrons (DDNs) from helical/stellarator plasmas.
The primary mission of the brand new TOFED is to review the supra-thermal deuterons generated from the auxiliary heating methods in helical plasmas by measuring the time-of-flight spectra of DDN. It can additionally measure the triton burnup neutrons (TBNs) from the d+t reactions, not like the unique TOFED within the EAST tokamak. Its functionality of diagnosing the TBN ratios is evaluated on this work.
This new TOFED is predicted to be put in within the basement beneath the LHD corridor and shares the collimator with one channel of the vertical neutron digital camera to outline its line of sight. The gap from its main scintillators to the equatorial airplane of LHD plasmas is about 15.5 m. Based mostly on Monte Carlo simulation by a GEANT4 mannequin, the decision of the DDN power spectra is 6.6%.
When projected onto the neutron charges which are sometimes obtained in LHD deuterium plasmas (an order of 1015 n/s with impartial beam injection), we count on to acquire the DDN and TBN counting charges of about 2.5 · 105 counts/s and 250 counts/s, respectively. This may permit us to research the DDN time-of-flight spectra on time scales of 0.1 s and diagnose the TBN emission charges in a number of seconds with one instrument, for the primary time in helical/stellarator plasmas.
 Performance of Handheld NaI(Tl) Spectrometers as Dosimeters by Laboratory and Field Dose Rate Measurements

Cell-phone digital camera Raman spectrometer

On this report, we describe the design, building, and operation of a cell-phone-based Raman and emission spectral detector, which when coupled to a diffraction grating and cell-phone digital camera system supplies means for the detection, recording, and identification of chemical substances, medicine, and organic molecules, in situ via their Raman and fluorescence spectra.
The newly constructed cell-phone spectrometer system was used to report Raman spectra from varied chemical substances and organic molecules together with the resonance enhanced Raman spectra of carrots and micro organism. As well as, we current the quantitative evaluation of alcohol-water Raman spectra, carried out utilizing our cell-phone spectrometer.
The designed and constructed system was additionally used for setting up Raman photos of the samples by using a place scanning stage together with the system. This compact and moveable system is nicely fitted to in situ area purposes of Raman and fluorescence spectroscopy and may additionally be an built-in characteristic of future cell-phones.

Ultrahigh delicate transient absorption spectrometer

Transient absorption (TA) spectroscopy is taken into account as a robust method that displays the ultrafast dynamics of photogenerated carriers in photoelectric and photocatalysis supplies. Nonetheless, restricted by its sensitivity, the photogenerated provider density in TA measurements of photo voltaic power supplies is normally a lot increased than that in the actual working situation.
Right here, we current a mixture of kHz macro-pulse and MHz micro-pulse method for an ultrahigh delicate TA spectrometer, which improves the sensitivity to the 10-7 stage of ΔOD. It allows us to review ultrafast provider dynamics pumped by very low energy, which might keep away from the affect of many-body interactions and the nonlinear impact related to excessive provider density.

Trifluoroacetic acid, Ultrapure for synthesis

GK2000-1 1
EUR 261

Trifluoroacetic acid, Ultrapure for synthesis

GK2000-100 100
EUR 39.4

TMP-PEG3-amine, trifluoroacetic acid salt

91056 1MG
EUR 234
Description: Minimum order quantity: 1 unit of 1MG

N-(6-Aminohexyl)maleimide, trifluoroacetic acid salt: (100mg)

91051 100MG
EUR 574.8
Description: Minimum order quantity: 1 unit of 100MG

Biotin-PEO2-PPO2-amine, trifluoroacetic acid salt:10mg

90078 10MG
EUR 241.2
Description: Minimum order quantity: 1 unit of 10MG

TRIFLUOROACETIC ANHYDRIDE

520009 each Ask for price

L-Alanine-7-amido-4-methylcoumarin trifluoroacetic acid salt

GC8079-250 250
EUR 172.7

L-Alanine-7-amido-4-methylcoumarin trifluoroacetic acid salt

GC8079-50 50
EUR 57

ARP (N-(Aminooxyacetyl)-N'-(D-biotinoyl)hydrazine, trifluoroacetic acid salt): (10mg)

90073 10MG
EUR 303.6
Description: Minimum order quantity: 1 unit of 10MG

Ro 26-4550 trifluoroacetate

B5176-10 10 mg
EUR 614.4
Description: IC50: 3 ?MRo 26-4550 trifluoroacetate is a competitive reversible inhibitor of interleukin-2 (IL-2) binding to its receptor [1]. Interleukin-2 (IL-2) (a 15.5 kDa cytokine) plays a predominant role in the growth of activated T cells.

GSK 256066 Trifluoroacetate

HY-70069 5mg
EUR 291.6

PHP 501 trifluoroacetate

B5608-10 10 mg
EUR 517.2

PHP 501 trifluoroacetate

B5608-50 50 mg
EUR 1987.2

PMX 205 Trifluoroacetate

HY-110136A 500ug
EUR 224.4

RGD Trifluoroacetate

HY-P0278A 25mg
EUR 391.2

BIBP 3226 trifluoroacetate

B7155-1 1 mg
EUR 321.6
Description: BIBP 3226 trifluoroacetate is a non-peptide neuropeptide Y Y1 (NPY Y1) and neuropeptide FF (NPFF) receptor antagonist with Ki values of 1.1, 79, 108 for rNPY Y1, hNPFF2, rNPFF, respectively. Neuropeptide Y Y1 receptors (NPY Y1) involve in the regulation of exploratory behaviour and anxiety.

BIBP 3226 trifluoroacetate

B7155-10 10 mg
EUR 642
Description: BIBP 3226 trifluoroacetate is a non-peptide neuropeptide Y Y1 (NPY Y1) and neuropeptide FF (NPFF) receptor antagonist with Ki values of 1.1, 79, 108 for rNPY Y1, hNPFF2, rNPFF, respectively. Neuropeptide Y Y1 receptors (NPY Y1) involve in the regulation of exploratory behaviour and anxiety.

BIBO 3304 trifluoroacetate

B7047-10 10 mg
EUR 654
Description: BIBO 3304 is a high affinity NPY Y1 receptor antagonist with IC50 values of 0.72 and 0.38 nM at rat and human receptors respectively [1].Neuropeptide Y is a 36 amino acid polypeptide that is expressed in the hypothalamus.

BIBO 3304 trifluoroacetate

B7047-50 50 mg
EUR 2563.2
Description: BIBO 3304 is a high affinity NPY Y1 receptor antagonist with IC50 values of 0.72 and 0.38 nM at rat and human receptors respectively [1].Neuropeptide Y is a 36 amino acid polypeptide that is expressed in the hypothalamus.

L-803,087 trifluoroacetate

B6904-10 10 mg
EUR 633.6

ARRY 520 trifluoroacetate

A4458-10 10 mg
EUR 393.6
Description: ARRY 520 trifluoroacetate is a synthetic and salt form of KSP inhibitor with IC50 value of 6 nM. Kinesin spindle protein (KSP) is one member of the mitotic kinesins involved in the early stages of mitosis responsible for centrosome separation.

ARRY 520 trifluoroacetate

A4458-25 25 mg
EUR 790.8
Description: ARRY 520 trifluoroacetate is a synthetic and salt form of KSP inhibitor with IC50 value of 6 nM. Kinesin spindle protein (KSP) is one member of the mitotic kinesins involved in the early stages of mitosis responsible for centrosome separation.

ARRY 520 trifluoroacetate

A4458-5 5 mg
EUR 247.2
Description: ARRY 520 trifluoroacetate is a synthetic and salt form of KSP inhibitor with IC50 value of 6 nM. Kinesin spindle protein (KSP) is one member of the mitotic kinesins involved in the early stages of mitosis responsible for centrosome separation.

ARRY 520 trifluoroacetate

A4458-100 100mg
EUR 2456
Description: KSP inhibitor

ARRY 520 trifluoroacetate

A4458-50 50mg
EUR 1455
Description: KSP inhibitor

TRIFLUOROACETAMIDE

920012 each Ask for price

ALX 40-4C Trifluoroacetate

HY-P7061A 5mg
EUR 1230

ADH-1 trifluoroacetate

HY-13541A 10mM/1mL
EUR 333.6

SB 290157 (trifluoroacetate salt)

C3563-10 10 mg
EUR 247.2
Description: IC50: 200 nMSB 290157 is a C3aR antagonist.The anaphylatoxin C3a, a potent chemotactic peptide and inflammatory mediator, binds to and activates a G-protein-coupled receptor.

SB 290157 (trifluoroacetate salt)

C3563-25 25 mg
EUR 454.8
Description: IC50: 200 nMSB 290157 is a C3aR antagonist.The anaphylatoxin C3a, a potent chemotactic peptide and inflammatory mediator, binds to and activates a G-protein-coupled receptor.

SB 290157 (trifluoroacetate salt)

C3563-5 5 mg
EUR 176.4
Description: IC50: 200 nMSB 290157 is a C3aR antagonist.The anaphylatoxin C3a, a potent chemotactic peptide and inflammatory mediator, binds to and activates a G-protein-coupled receptor.

PPACK II, trifluoroacetate

B2151-5 each
EUR 352.8

4-(Trifluoroacetyl)toluene

20-abx183477
  • EUR 326.40
  • EUR 1395.60
  • EUR 594.00
  • 1 g
  • 25 g
  • 5 g

Methyl trifluoroacetate

20-abx184730
  • EUR 243.60
  • EUR 326.40
  • 100 g
  • 500 g

GSK-121 trifluoroacetate

B1034-1000 each
EUR 222

GSK-121 trifluoroacetate

B1034-500 each
EUR 157.2

AT7519 trifluoroacetate

A3198-10 10 mg
EUR 223.2
Description: AT7519 is a kinase inhibitor with IC50 of 0.19, 0.044, 0.51, 0.067, 0.66 and 0.018 ?M for CDK1/cyclinB, CDK2/CyclinA, CDK2/Cyclin E, CDk4/CyclinD1, CDK6/Cyclin D3, CDk5/p35.

AT7519 trifluoroacetate

A3198-100 100 mg
EUR 512.4
Description: AT7519 is a kinase inhibitor with IC50 of 0.19, 0.044, 0.51, 0.067, 0.66 and 0.018 ?M for CDK1/cyclinB, CDK2/CyclinA, CDK2/Cyclin E, CDk4/CyclinD1, CDK6/Cyclin D3, CDk5/p35.

AT7519 trifluoroacetate

A3198-5 5 mg
EUR 166.8
Description: AT7519 is a kinase inhibitor with IC50 of 0.19, 0.044, 0.51, 0.067, 0.66 and 0.018 ?M for CDK1/cyclinB, CDK2/CyclinA, CDK2/Cyclin E, CDk4/CyclinD1, CDK6/Cyclin D3, CDk5/p35.

AT7519 trifluoroacetate

A3198-50 50 mg
EUR 404.4
Description: AT7519 is a kinase inhibitor with IC50 of 0.19, 0.044, 0.51, 0.067, 0.66 and 0.018 ?M for CDK1/cyclinB, CDK2/CyclinA, CDK2/Cyclin E, CDk4/CyclinD1, CDK6/Cyclin D3, CDk5/p35.

AT7519 (trifluoroacetate)

HY-50940A 50mg
EUR 321.6

MK-8245 (Trifluoroacetate)

HY-13077 50mg
EUR 878.4

Silver trifluoroacetate, 97+%

GX7211-25 25
EUR 277.1

Silver trifluoroacetate, 97+%

GX7211-5 5
EUR 114.5

Sodium trifluoroacetate, 97+%

GX3440-50 50
EUR 123.5

GSK2807 Trifluoroacetate

HY-104009A 100mg
EUR 2264.4

XMD-17-51 Trifluoroacetate

HY-117291A 10mM/1mL
EUR 453.6

GGTI298 Trifluoroacetate

HY-15871 25mg
EUR 817.2

2,4,6-Trifluoroacetophenone

20-abx182978
  • EUR 360.00
  • EUR 661.20
  • 1 g
  • 5 g

3-Bromo-1,1,1-trifluoroacetone

20-abx183344
  • EUR 477.60
  • EUR 292.80
  • 100 g
  • 25 g

NGR peptide Trifluoroacetate

HY-P1043A 5mg
EUR 555.6

Cyclo(RGDyK) trifluoroacetate

HY-100563 10mM/1mL
EUR 291.6

SB290157 (trifluoroacetate)

HY-101502A 50mg
EUR 538.8

Bestatin (trifluoroacetate)

HY-B0134B 50mg
EUR 357.6

ATN-161 (trifluoroacetate salt)

HY-13535A 10mg
EUR 280.8

N-(Trifluoroacetyl) Imidazole

42000076-1 5 mL
EUR 104.31

1,1,1-Trifluoroacetylacetone

20-abx182816
  • EUR 493.20
  • EUR 292.80
  • EUR 226.80
  • 100 g
  • 25 g
  • 5 g

Palladium(II) trifluoroacetate

20-abx186081
  • EUR 393.60
  • EUR 1897.20
  • EUR 760.80
  • 1 g
  • 25 g
  • 5 g

PPACKII (trifluoroacetate salt)

C3393-10 10 mg
EUR 423.6
Description: PPACKII is a specific and irreversible inhibitor of glandular and plasma kallikreins [1]. Human tissue kallikreins (hKs) are a class of secreted serine proteases that involved in the release of vasodepressor peptides or kinins from a plasma substrate.

PPACKII (trifluoroacetate salt)

C3393-25 25 mg
EUR 908.4
Description: PPACKII is a specific and irreversible inhibitor of glandular and plasma kallikreins [1]. Human tissue kallikreins (hKs) are a class of secreted serine proteases that involved in the release of vasodepressor peptides or kinins from a plasma substrate.

PPACKII (trifluoroacetate salt)

C3393-5 5 mg
EUR 265.2
Description: PPACKII is a specific and irreversible inhibitor of glandular and plasma kallikreins [1]. Human tissue kallikreins (hKs) are a class of secreted serine proteases that involved in the release of vasodepressor peptides or kinins from a plasma substrate.

LL-37 (human) trifluoroacetate salt

L046-1MG 1 mg
EUR 205.2

Pepstatin Trifluoroacetate

HY-P0018A 10mM/1mL
EUR 135.6

c-Myc Peptide Trifluoroacetate

HY-P0312 10mg
EUR 523.2

EPZ011989 (trifluoroacetate)

HY-16986A 50mg
EUR 445.2

UNC0321 tri(trifluoroacetate salt)

B2837-1 each
EUR 130.8

UNC0321 tri(trifluoroacetate salt)

B2837-5 each
EUR 314.4

F-Amidine (trifluoroacetate salt)

B2803-100 each
EUR 157.2

F-Amidine (trifluoroacetate salt)

B2803-500 each
EUR 418.8

Dolastatin 10 trifluoroacetate

B1066-1 1 mg
EUR 787.2
Description: Dolastatin 10 trifluoroacetate is an antitumor agent [1].Dolastatin 10 trifluoroacetate is a potent antimitotic polypeptide isolated from a marine animal and is developed as a potential antitumor agent.

Dolastatin 10 trifluoroacetate

B1066-5 5 mg
EUR 2043.6
Description: Dolastatin 10 trifluoroacetate is an antitumor agent [1].Dolastatin 10 trifluoroacetate is a potent antimitotic polypeptide isolated from a marine animal and is developed as a potential antitumor agent.

Taltobulin trifluoroacetate

ADC-P-028 unit Ask for price

PYRIDINIUM TRIFLUOROACETATE

516009 each Ask for price

Vandetanib (trifluoroacetate)

HY-10260A 100mg
EUR 357.6

Taltobulin (trifluoroacetate)

HY-15584A 50mg
EUR 1368

Rapastinel (Trifluoroacetate)

HY-16728B 10mM/1mL
EUR 396

Cl-Amidine (trifluoroacetate salt)

C3829-10 10 mg
EUR 325.2
Description: IC50: 5.9 ?MCl-Amidine is a PAD4 deimination activity inhibitor.Protein arginine deiminase 4 (PAD4) can catalyze the post-translational modification of arginine residues on histones to form citrulline, which can change gene expression.

Cl-Amidine (trifluoroacetate salt)

C3829-5 5 mg
EUR 226.8
Description: IC50: 5.9 ?MCl-Amidine is a PAD4 deimination activity inhibitor.Protein arginine deiminase 4 (PAD4) can catalyze the post-translational modification of arginine residues on histones to form citrulline, which can change gene expression.

VU0364572 (trifluoroacetate salt)

C4396-1 1 mg
EUR 138
Description: IC50: 477 ± 172 nMVU0364572 is a M1 agonist.Alzheimer's disease (AD) is the leading cause of dementia worldwide, and no disease-modifying therapy is availables.

VU0364572 (trifluoroacetate salt)

C4396-10 10 mg
EUR 687.6
Description: IC50: 477 ± 172 nMVU0364572 is a M1 agonist.Alzheimer's disease (AD) is the leading cause of dementia worldwide, and no disease-modifying therapy is availables.

VU0364572 (trifluoroacetate salt)

C4396-25 25 mg
EUR 1434
Description: IC50: 477 ± 172 nMVU0364572 is a M1 agonist.Alzheimer's disease (AD) is the leading cause of dementia worldwide, and no disease-modifying therapy is availables.

VU0364572 (trifluoroacetate salt)

C4396-5 5 mg
EUR 414
Description: IC50: 477 ± 172 nMVU0364572 is a M1 agonist.Alzheimer's disease (AD) is the leading cause of dementia worldwide, and no disease-modifying therapy is availables.

Bivalirudin Trifluoroacetate

A3244-100 100 mg
EUR 234
Description: BivalirudinTrifluoroacetate is a specific, reversible and direct thrombin inhibitor with a predictable anticoagulant effect.In patients with normal or mildly impaired renal function, bivalirudin exihibited several notable mechanistic advantages when compared with unfractionated heparin.

Bivalirudin Trifluoroacetate

A3244-500 500 mg
EUR 584.4
Description: BivalirudinTrifluoroacetate is a specific, reversible and direct thrombin inhibitor with a predictable anticoagulant effect.In patients with normal or mildly impaired renal function, bivalirudin exihibited several notable mechanistic advantages when compared with unfractionated heparin.

Gardiquimod trifluoroacetate

HY-103697A 100mg
EUR 721.2

4-Nitrophenyl trifluoroacetate

20-abx183638
  • EUR 410.40
  • EUR 260.40
  • EUR 210.00
  • 100 g
  • 25 g
  • 5 g

N-[2-Iodoethyl]trifluoroacetamide

20-abx180835
  • EUR 678.00
  • EUR 1646.40
  • 1 g
  • 5 g

4-(Trifluoroacetyl)benzoyl chloride

GW0017-1 1
EUR 123.3

4-(Trifluoroacetyl)benzoyl chloride

GW0017-5 5
EUR 208.7

V5 Epitope Tag Peptide Trifluoroacetate

HY-P0325 10mg
EUR 408

5-ROX Cadaverine Trifluoroacetate salt

91060 1MG
EUR 220
Description: N/A

Phe-Met-Arg-Phe amide trifluoroacetate

HY-P0249A 25mg
EUR 374.4

biotin cadaverine, trifluoroacetate salt

90063 50MG
EUR 225.6
Description: Minimum order quantity: 1 unit of 50MG

6-TAMRA Cadaverine, Trifluoroacetate Salt

90122 1MG
EUR 129
Description: N/A

Bis(trimethylsilyl)trifluoroacetamide

GK7139-25 25
EUR 40.9

Bis(trimethylsilyl)trifluoroacetamide

GK7139-5 5
EUR 21.4

N,O-Bis(Trimethylsilyl)Trifluoroacetamide

20-abx188805
  • EUR 678.00
  • EUR 260.40
  • EUR 1144.80
  • EUR 444.00
  • 10 g
  • 1 g
  • 25 g
  • 5 g

N,O-Bis(trimethylsilyl)trifluoroacetamide

05102-04 10ML
EUR 119

N,O-Bis(trimethylsilyl)trifluoroacetamide

05102-91 1ML
EUR 27.3

4-Amino-2-piperidinone trifluoroacetate

20-abx180494
  • EUR 727.20
  • EUR 1796.40
  • 1 g
  • 5 g

Biotin-X cadaverine, trifluoroacetate salt: (20mg)

90061 20MG
EUR 225.6
Description: Minimum order quantity: 1 unit of 20MG

Carboxy pyridostatin trifluoroacetate salt

HY-112680A 5mg
EUR 542.4

N,O‐BIS‐(TRIMETHYLSILYL) TRIFLUOROACETAMIDE (BSTFA)

902006 each Ask for price

Lactoferricin B fragment 4-14 trifluoroacetate salt

L043-1MG 1 mg
EUR 238.8

4-pentynoyl-Coenzyme A (trifluoroacetate salt)

B2838-1000 each
EUR 379.2

4-pentynoyl-Coenzyme A (trifluoroacetate salt)

B2838-500 each
EUR 235.2

Bis(trimethylsilyl)trifluoroacetamide with 1% TMCS

GK0113-1G 1 g
EUR 50.4

Bis(trimethylsilyl)trifluoroacetamide with 1% TMCS

GK0113-1 1
EUR 13

Octreotide trifluoroacetate salt (Dimer, Parallel)

H-7374.0500 0.5mg
EUR 480
Description: Sum Formula: C98H132N20O20S4; CAS# [1926163-80-5] net

Octreotide trifluoroacetate salt (Dimer, Parallel)

H-7374.1000 1.0mg
EUR 776.4
Description: Sum Formula: C98H132N20O20S4; CAS# [1926163-80-5] net

N-Methyl-N-(trimethylsilyl)trifluoroacetamide

GK6777-100 100
EUR 310.3

N-Methyl-N-(trimethylsilyl)trifluoroacetamide

GK6777-25 25
EUR 112.3

N-Methyl-N-(trimethylsilyl)trifluoroacetamide

GK6777-5 5
EUR 37.7

1,3-Diethyl2-(2,2,2-trifluoroacetamido)propanedioate

20-abx186125
  • EUR 878.40
  • EUR 2214.00
  • 1 g
  • 5 g

2-Sulforhodamine 101 cadaverine, trifluoroacete salt

90115 5MG
EUR 410.4
Description: Minimum order quantity: 1 unit of 5MG

4-Sulforhodamine 101 cadaverine, trifluoroacete salt

90116 5MG
EUR 410.4
Description: Minimum order quantity: 1 unit of 5MG

N-(6-Aminohexyl)rhodamine 6G-amide bis(trifluoroacetate)

GW7025-10 10
EUR 161.8

N-(6-Aminohexyl)rhodamine 6G-amide bis(trifluoroacetate)

GW7025-50 50
EUR 405.4

Octreotide trifluoroacetate salt (Dimer, Antiparallel)

H-7376.0500 0.5mg
EUR 480
Description: Sum Formula: C98H132N20O20S4; CAS# [1926163-78-1] net

Octreotide trifluoroacetate salt (Dimer, Antiparallel)

H-7376.1000 1.0mg
EUR 776.4
Description: Sum Formula: C98H132N20O20S4; CAS# [1926163-78-1] net

Rhodamine 6G p-diaminoxylene amide bis (trifluoroacetate)

GW3287-250 250
EUR 793.5

Rhodamine 6G p-diaminoxylene amide bis (trifluoroacetate)

GW3287-50 50
EUR 252.7

Rhodamine 6G bis(aminoethyl)amine amide bis (trifluoroacetate)

GW3542-250 250
EUR 786.5

Rhodamine 6G bis(aminoethyl)amine amide bis (trifluoroacetate)

GW3542-50 50
EUR 251.3

Rhodamine 6G ethylenediamine amide bis (trifluoroacetate)

GW3583-10 10
EUR 161.8

Rhodamine 6G ethylenediamine amide bis (trifluoroacetate)

GW3583-50 50
EUR 405.4

Rhodamine 6G bis(oxyethylamino)ethane amide bis (trifluoroacetate)

GW0572-250 250
EUR 786.5

Rhodamine 6G bis(oxyethylamino)ethane amide bis (trifluoroacetate)

GW0572-50 50
EUR 251.3

N-(tert-Butyldimethylsilyl)-N-methyl trifluoroacetamide

GK4999-10 10
EUR 110.7

N-(tert-Butyldimethylsilyl)-N-methyl trifluoroacetamide

GK4999-25 25
EUR 221.5

N-(tert-Butyldimethylsilyl)-N-methyl trifluoroacetamide

GK4999-5 5
EUR 67.2

Fluorescein cadaverine (5-((5-aminopentyl) thioureidyl)fluorescein, trifluoroacetate salt): (25mg)

92000 25MG
EUR 276
Description: Minimum order quantity: 1 unit of 25MG

2-(Trifluoromethyl)-3,3,3-trifluoropropionic acid

abx181620-1g 1 g
EUR 276

2,3,4-Trifluorobenzoic acid

GK5123-25 25
EUR 118.7

2,3,4-Trifluorobenzoic acid

GK5123-5 5
EUR 31.7

2,4,5‐TRIFLUOROPHENYLACETIC ACID

920016 each Ask for price

Trifluoromethanesulfonic acid

abx184793-500g 500 g
EUR 460.8

TRIFLUOROMETHANESULFONIC ACID

1020004 each Ask for price

Trifluoromethanesulfonic acid

GC7093-10G 10 g
EUR 66

Trifluoromethanesulfonic acid

GC7093-25G 25 g
EUR 96

Trifluoromethanesulfonic acid

GC7093-10 10
EUR 24.8

Trifluoromethanesulfonic acid

GC7093-25 25
EUR 49.4

2-(Trifluoromethyl)Benzoic Acid

abx188160-250g 250 g
EUR 1279.2

2-(Trifluoromethoxy)benzoic acid

20-abx185701
  • EUR 393.60
  • EUR 260.40
  • EUR 927.60
  • EUR 226.80
  • 100 g
  • 25 g
  • 500 g
  • 5 g

2,4,5-Trifluoro-3-methylbenzoic acid

20-abx182971
  • EUR 410.40
  • EUR 811.20
  • 1 g
  • 5 g

2,4,6-Trifluorobenzeneboronic Acid

20-abx182979
  • EUR 644.40
  • EUR 210.00
  • EUR 309.60
  • EUR 226.80
  • 100 g
  • 1 g
  • 25 g
  • 5 g

3,3,3-Trifluoro-2,2-dimethylpropionic acid

20-abx181855
  • EUR 360.00
  • EUR 878.40
  • 1 g
  • 5 g

3-Bromo-2,4,5-Trifluorobenzoic Acid

abx188353-100g 100 g
EUR 1296

2,5‐BIS(2,2,2‐TRIFLUOROETHOXY)BENZOIC ACID

502020 each Ask for price

3-Chloro-2,4,5-trifluorobenzoic acid

20-abx181930
  • EUR 844.80
  • EUR 460.80
  • EUR 260.40
  • 100 g
  • 25 g
  • 5 g

4-(Trifluoromethyl)Phenylboronic Acid

20-abx180473
  • EUR 577.20
  • EUR 226.80
  • EUR 326.40
  • EUR 1378.80
  • EUR 243.60
  • 100 g
  • 1 g
  • 25 g
  • 500 g
  • 5 g

P-(Trifluoromethoxy)Phenylboronic Acid

20-abx182615
  • EUR 477.60
  • EUR 210.00
  • EUR 276.00
  • EUR 1429.20
  • EUR 226.80
  • 100 g
  • 1 g
  • 25 g
  • 500 g
  • 5 g

4-(1-Azi-2,2,2-trifluoroethyl)benzoic acid

Q-1540.0025 25.0mg
EUR 907.2
Description: Sum Formula: C9H5F3N2O2; CAS# [85559-46-2]

4-(1-Azi-2,2,2-trifluoroethyl)benzoic acid

Q-1540.0100 100.0mg
EUR 2648.4
Description: Sum Formula: C9H5F3N2O2; CAS# [85559-46-2]

Benzenepropanoic acid,4-(trifluoromethyl)-

20-abx182372
  • EUR 944.40
  • EUR 444.00
  • 25 g
  • 5 g

Benzenepropanoic acid,2-(trifluoromethyl)-

20-abx183870
  • EUR 292.80
  • EUR 1095.60
  • EUR 493.20
  • 1 g
  • 25 g
  • 5 g

Acetic acid,2,2,2-trifluoro-, aluminum salt (3:1)

20-abx182362
  • EUR 326.40
  • EUR 577.20
  • 1 g
  • 5 g

4-Methyl-3-(trifluoromethyl)benzoic acid

20-abx183624
  • EUR 343.20
  • EUR 1479.60
  • EUR 627.60
  • 1 g
  • 25 g
  • 5 g

3-(3-Trifluoromethylphenyl)propionic acid

20-abx183273
  • EUR 292.80
  • EUR 961.20
  • EUR 460.80
  • 1 g
  • 25 g
  • 5 g

4'-(Trifluoromethyl)-4-Biphenylboronic Acid

20-abx185167
  • EUR 326.40
  • EUR 844.80
  • EUR 444.00
  • 100 mg
  • 1 g
  • 250 mg

3,5-Bis(Trifluoromethyl)Benzeneboronic Acid

20-abx185757
  • EUR 360.00
  • EUR 260.40
  • EUR 210.00
  • 100 g
  • 25 g
  • 5 g

4-Hydroxy-3-(Trifluoromethyl)Benzoic Acid

20-abx183603
  • EUR 477.60
  • EUR 2749.20
  • EUR 1045.20
  • 1 g
  • 25 g
  • 5 g

2-Fluoro-5-(Trifluoromethoxy)Benzoic Acid

20-abx187886
  • EUR 727.20
  • EUR 1429.20
  • 1 g
  • 5 g

2-Chloro-6-(trifluoromethyl)nicotinic acid

20-abx181781
  • EUR 627.60
  • EUR 260.40
  • EUR 1111.20
  • EUR 444.00
  • 10 g
  • 1 g
  • 25 g
  • 5 g

(S)-3,3,3-Trifluoro-2-Hydroxy-2-Methylpropionic Acid

20-abx180937
  • EUR 326.40
  • EUR 594.00
  • 1 g
  • 5 g

(5-Trifluoromethyl-pyridin-2-yl)-acetic acid

abx182712-1g 1 g
EUR 727.2
This work supplies a novel TA technique with ultrahigh sensitivity, which is able to play an vital function in investigating the provider dynamics of semiconductors within the working situation.

Leave a Reply

Your email address will not be published. Required fields are marked *